Drugs / Nituozumab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05831930 | Jan 2023 → Jan 2026 | head and neck squamous cell carcinoma | Sichuan Cancer Hospital and Research Institute | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nituozumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831930 ↗ |